510(k) Report

510(k) · Cleared

Cleared

FirstSense Breast Exam

K160573510(k) TraditionalCleared Jun 1, 201693-day reviewClass I21 CFR 884.2980

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

First Sense Medical, LLC · LHQ System, Telethermographic (Adjunctive Use)

Cleared on Jun 1, 2016 as substantially equivalent to K032350 (Infrared Sciences Corp., 2004) after a 93-day review. Its family tree reaches back 4 generations to 1995.

Decided
Jun 1, 2016
Review
93 days
Class
Class I
Product code
LHQ
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K951806 (1995). 7 ancestors in all, the oldest K812799 (1981). No later device cites it as a predicate yet.

  1. Root · 4 generations backK951806 Opgal Intraoperative Vascular Angiography System (Iva-2000)Opgal Optronic Industries · 1995
  2. 3 generations backK982327 Inframetrics Infracam-MedInframetrics, Inc. · 1998
  3. 2 generations backK990416 Omnicorder Bioscan SystemOmnicorder Technologies, Inc. · 1999
  4. 1 generation backK032350 Infrared Sciences Breastscan IR SystemInfrared Sciences Corp. · 2004
  5. This deviceK160573 FirstSense Breast ExamFirst Sense Medical, LLC · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K951806Opgal Intraoperative Vascular Angiography System (Iva-2000)Opgal Optronic Industries1995—
−3K982327Inframetrics Infracam-MedInframetrics, Inc.1998—
−2K990416Omnicorder Bioscan SystemOmnicorder Technologies, Inc.1999—
−1K032350Infrared Sciences Breastscan IR SystemInfrared Sciences Corp.2004—
0 (this device)K160573FirstSense Breast ExamFirst Sense Medical, LLC2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198110
198210
199010
FIG. 1 — Lineage of K160573, 1995–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LHQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LHQ device

  1. #1 K253911 Derma-2score 12.0 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032350Infrared Sciences Breastscan IR System
Summary page 4
…Common/Classification Name Telethermographic System (Adjunctive Use) (Product Code: LHQ; 21 C.F.R. 884.2980) Predicate Device Infrared Sciences Corp., BreastScan IR (K032350) Intended Use / Indications for Use The FIRSTSense Breast Exam® device is intended for viewing and recording heat patterns gene…
Infrared Sciences Corp.2004—

Also cleared against K032350: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 5 companies; a new generation was cleared every 4.2 years on median.
  • None of the 7 ancestors has a recall.
  • 1 other device also cites its predicate K032350.

How does its category compare?

All LHQ devices

LHQ System, Telethermographic (Adjunctive Use): FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · LHQ

1in 2023

2008: 12011: 12012: 12015: 12016: 12017: 22019: 12021: 22022: 22023: 12026 (partial year): 1
2007high 2 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LHQ

Too few LHQ 510(k)s in any year since 2007 to give a median.

Recalls per year · LHQ

No recall names LHQ since 2007.

Adverse event reports per year · LHQ

1in 2025

2013: 12019: 22020: 12021: 12025: 1
2007high 2 (2019) · low 0 (2007)2025

MAUDE reports naming product code LHQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20090—00
20100—00
20111—00
20121—00
20130—01
20140—00
20151—00
20161—00
20172—00
20180—00
20191—02
20200—01
20212—01
20222—00
20231—00
20240—00
20250—01
20261—0—

What is it indicated for?

The FIRSTSense Breast Exam® device is intended for viewing and recording heat patterns

generated by the human body in the hospital, acute care settings, outpatient surgery, healthcare

practitioner facilities, or in an environment where patient care is provided by qualified healthcare

personnel. It is intended for use in adult patient populations. The device is for adjunctive diagnostic

screening for detection of breast cancer and diseases affecting blood perfusion or reperfusion of

tissue or organs. This device is intended for use by qualified healthcare personnel trained in its use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K160573: FirstSense Breast Exam.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K160573

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026